Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0E42
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,027
Award facts
- Contract value 100% obligated
- $1,026.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,026.96 by the Defense Logistics Agency on November 24, 2025. This firm fixed-price delivery order represents one of numerous purchases issued to the contractor under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Department of Defense acquisition strategy designed to consolidate pharmaceutical supply across military healthcare facilities worldwide. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is funded by the Defense Logistics Agency and has an ultimate completion date of November 25, 2025.
This delivery order falls under DMS Pharmaceutical Group's broader single-award Indefinite Delivery Contract (SPE2DR) established under PPV-G GEN V, which was awarded on November 13, 2025, with a ceiling value of $499,999,999 and extends through December 31, 2036. The IDC authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally. The contractor's established performance across multiple therapeutic categories and specialized pharmaceutical products positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DU26F0E42?
SPE2DU26F0E42 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DU26F0E42 worth?
The government has obligated $1,027 on SPE2DU26F0E42.
Is contract SPE2DU26F0E42 an order under another contract?
Yes. SPE2DU26F0E42 is a delivery order under SPE2DU25D9815, an indefinite delivery contract.
Was contract SPE2DU26F0E42 competed?
The extent of competition for SPE2DU26F0E42 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award